These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2882446)

  • 1. Region-specific loss of glutamate innervation in Alzheimer's disease.
    Hardy J; Cowburn R; Barton A; Reynolds G; Lofdahl E; O'Carroll AM; Wester P; Winblad B
    Neurosci Lett; 1987 Jan; 73(1):77-80. PubMed ID: 2882446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease.
    Cowburn R; Hardy J; Roberts P; Briggs R
    Brain Res; 1988 Jun; 452(1-2):403-7. PubMed ID: 2900052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A postmortem study of amino acid neurotransmitters in Alzheimer's disease.
    Ellison DW; Beal MF; Mazurek MF; Bird ED; Martin JB
    Ann Neurol; 1986 Nov; 20(5):616-21. PubMed ID: 2878639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex.
    Scott HL; Tannenberg AE; Dodd PR
    J Neurochem; 1995 May; 64(5):2193-202. PubMed ID: 7722505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
    Greenamyre JT; Penney JB; D'Amato CJ; Young AB
    J Neurochem; 1987 Feb; 48(2):543-51. PubMed ID: 2878980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
    Chalmers DT; Dewar D; Graham DI; Brooks DN; McCulloch J
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamatergic denervation in Alzheimer's disease--a cautionary note.
    Procter AW; Palmer AM; Bowen DM; Murphy E; Neary D
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):825. PubMed ID: 2886557
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type.
    Sasaki H; Muramoto O; Kanazawa I; Arai H; Kosaka K; Iizuka R
    Ann Neurol; 1986 Mar; 19(3):263-9. PubMed ID: 2870679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of aspartate and glutamate caused by chloride reduction in synaptosomal incubation media.
    Hardy JA; Boakes RJ; Thomas DJ; Kidd AM; Edwardson JA; Virmani M; Turner J; Dodd PR
    J Neurochem; 1984 Mar; 42(3):875-7. PubMed ID: 6141228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease.
    Lowe SL; Bowen DM; Francis PT; Neary D
    Neuroscience; 1990; 38(3):571-7. PubMed ID: 1980143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.
    Rylett RJ; Ball MJ; Colhoun EH
    Brain Res; 1983 Dec; 289(1-2):169-75. PubMed ID: 6661641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone.
    Hyman BT; Van Hoesen GW; Damasio AR
    Ann Neurol; 1987 Jul; 22(1):37-40. PubMed ID: 2443073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Binding' of glutamate and asparatate to synaptosomal fractions of six regions of the feline brain.
    De Feudis FV; Madtes P; Ojeda A; Gadea-Ciria M
    Experientia; 1976 Aug; 32(8):1014-5. PubMed ID: 955005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A disorder of cortical GABAergic innervation in Alzheimer's disease.
    Hardy J; Cowburn R; Barton A; Reynolds G; Dodd P; Wester P; O'Carroll AM; Lofdahl E; Winblad B
    Neurosci Lett; 1987 Jan; 73(2):192-6. PubMed ID: 3822251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease.
    Cowburn R; Hardy J; Roberts P; Briggs R
    Neurosci Lett; 1988 Mar; 86(1):109-13. PubMed ID: 2896322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.
    Rothstein JD; Martin LJ; Kuncl RW
    N Engl J Med; 1992 May; 326(22):1464-8. PubMed ID: 1349424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine lesions in the rat hippocampus mimic the alterations of several markers in Alzheimer's disease.
    Nakagawa Y; Nakamura S; Kaśe Y; Noguchi T; Ishihara T
    Brain Res; 1987 Apr; 408(1-2):57-64. PubMed ID: 2885069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterocarrier-mediated reciprocal modulation of glutamate and glycine release in rat cerebral cortex and spinal cord synaptosomes.
    Bonanno G; Vallebuona F; Donadini F; Fontana G; Fedele E; Raiteri M
    Eur J Pharmacol; 1994 Jan; 252(1):61-7. PubMed ID: 7908643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study.
    Klunk WE; Panchalingam K; Moossy J; McClure RJ; Pettegrew JW
    Neurology; 1992 Aug; 42(8):1578-85. PubMed ID: 1353623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short-term hypoxia on [3H]glutamate release from preloaded hippocampal and cortical synaptosomes.
    Collard KJ; Menon-Johansson AS
    Neurochem Res; 1993 Feb; 18(2):165-70. PubMed ID: 8097288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.